Akari Therapeutics Plc Share Price (NASDAQ: AKTX)

$0.78

▲

-0.03

(-3.7%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Akari Therapeutics Plc Stock chart to analyse performance

Akari Therapeutics Plc stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$0.78
Today's High:$0.80
$0.78
0.0%
Downside
Day's Volatility :2.5%
Upside
2.5%
52 Weeks Low:$0.78
52 Weeks High:$3.87
$0.78
0.0%
Downside
52 Weeks Volatility :79.84%
Upside
79.84%

Akari Therapeutics Plc Stock Returns

Period	Akari Therapeutics Plc	Index (Russel 2000)
3 Months	-44.52%	0.0%
6 Months	-16.21%	0.0%
1 Year	-78.64%	0.0%
3 Years	-96.56%	-4.7%

Akari Therapeutics Plc Key Stats

Check Akari Therapeutics Plc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$0.81
Open	$0.801
Today's High	$0.8
Today's Low	$0.78
Market Capitalization	$26.3M
Today's Volume	$26.0K
52 Week High	$3.87
52 Week Low	$0.78
Revenue TTM	$0.0
EBITDA	$-12.8M
Earnings Per Share (EPS)	$0.0
PE Ratio	0.0
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-112.02%

Stock Returns calculator for Akari Therapeutics Plc Stock including INR - Dollar returns

The Akari Therapeutics Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Akari Therapeutics Plc investment value today

Current value as on today

₹25,650

Returns

₹74,350

(-74.35%)

Returns from Akari Therapeutics Plc Stock

₹79,634 (-79.63%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Akari Therapeutics Plc Stock

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Akari Therapeutics Plc Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Akari Therapeutics Plc

Name
Holdings %
Name
Holdings %
Palo Alto Investors, LLC
0.45%
Omnia Family Wealth, LLC
0.19%
HPM Partners LLC
0.07%
Cresset Asset Management, LLC
0.06%
Renaissance Technologies Corp
0.06%
Accent Capital Management LLC
0.03%

Analyst Recommendation on Akari Therapeutics Plc Stock

Rating

Trend

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Akari Therapeutics Plc(by analysts ranked 0 to 5 stars)

Akari Therapeutics Plc Share Price Target

What analysts predicted

Upside of 669.23%

Target:

$6.00

Current:

$0.78

Akari Therapeutics Plc share price target is $6.00, a slight Upside of 669.23% compared to current price of $0.78 as per analysts' prediction.

Akari Therapeutics Plc Stock Insights

Price Movement
In the last 7 days, AKTX stock has moved down by -14.8%
AKTX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 149.4%
AKTX vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 209.3%

Akari Therapeutics Plc Technicals Summary

Sell

Neutral

Buy

Akari Therapeutics Plc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Akari Therapeutics Plc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Akari Therapeutics Plc	-23.78%	-16.21%	-78.64%	-96.56%	-97.62%
Regeneron Pharmaceuticals, Inc.	6.48%	-15.2%	-50.31%	-3.3%	-2.01%
Beone Medicines Ltd	1.77%	24.81%	62.78%	79.11%	29.69%
Vertex Pharmaceuticals Incorporated	-14.45%	-19.13%	-17.84%	34.68%	41.87%
Alnylam Pharmaceuticals, Inc.	13.79%	83.28%	75.87%	111.28%	242.25%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Akari Therapeutics Plc	0.0	0.0	0.0	-0.45	-1.12	-0.29	NA	0.79
Regeneron Pharmaceuticals, Inc.	14.6	14.6	1.2	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.73	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.86	27.86	0.58	18.06	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Akari Therapeutics Plc	Buy	$26.3M	-97.62%	0.0	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$61.4B	-2.01%	14.6	31.37%
Beone Medicines Ltd	NA	$36.5B	29.69%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$100.5B	41.87%	27.86	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$59.5B	242.25%	NA	-12.96%

About Akari Therapeutics Plc

Akari Therapeutics, Plc, an oncology company, develops next-generation antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company's lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2 antibody to treat solid tumor cancer types, including lung, breast, colon, and prostate. Its payloads include PH5, which inhibits DNA mismatch repair (MMR) and DNA damage response (DDR) to generate neoepitopes, and PH6, which inhibits DNA transcription in cancer cells and co-opted immune cells. The company also develops AKTX-102, a novel bispecific ADC that utilizes PH1 as its payload to treat various solid tumor cancers. Akari Therapeutics, Plc is headquartered in Boston, Massachusetts.

Organization	Akari Therapeutics Plc
Employees	8
CEO	Mr. Abizer Gaslightwala
Industry	Health Technology

Key Management of Akari Therapeutics Plc

Name	Title
Mr. Abizer Gaslightwala	CEO, President & Director
Dr. Torsten Hombeck Ph.D.	Chief Financial Officer
Dr. Satyajit Mitra Ph.D.	Executive Director & Head of Oncology
Mr. Mark F. Kubik M.B.A.	Head of Business Development - Oncology

Important FAQs about investing in AKTX Stock from India :

What is Akari Therapeutics Plc share price today?

Akari Therapeutics Plc share price today is $0.78 as on August 30, 2025 at 1:29 am IST at the close of the market. Akari Therapeutics Plc share today touched a day high of $0.80 and a low of $0.78.

What is the 52 week high and 52 week low for Akari Therapeutics Plc share?

Akari Therapeutics Plc share touched a 52 week high of $3.87 and a 52 week low of $0.78. Akari Therapeutics Plc stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $0.78, lower by 79.84% versus the 52 week high.

How to invest in Akari Therapeutics Plc Stock (AKTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Akari Therapeutics Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Akari Therapeutics Plc Shares that will get you 1.9231 shares as per Akari Therapeutics Plc share price of $0.78 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Akari Therapeutics Plc Stock (AKTX) from India?

Indian investors can start investing in Akari Therapeutics Plc (AKTX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Akari Therapeutics Plc stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Akari Therapeutics Plc share’s latest price of $0.78 as on August 30, 2025 at 1:29 am IST, you will get 12.8205 shares of Akari Therapeutics Plc. Learn more about fractional shares .

What are the returns that Akari Therapeutics Plc has given to Indian investors in the last 5 years?

Akari Therapeutics Plc stock has given -97.62% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?